A

Aclaris Therapeutics
D

ACRS

3.89000
USD
0.14
(3.73%)
Market Closed
Volume
38,659
EPS
-1
Div Yield
-
P/E
-7
Market Cap
421,462,980
Overview
Related Instruments
A
ADUS
101.430 USD
0.450
(0.45%)
A
AIHS
1.63000 USD
0.08000
(5.16%)
A
ALXO
2.16500 USD
0.08500
(4.09%)
BMY
BMY
59.720 USD
0.010
(0.02%)
C
CAPR
31.170 USD
0.625
(2.05%)
C
CGC
1.07500 USD
0.06500
(6.44%)
C
CHRS
1.69000 USD
0.02000
(1.20%)
C
CRIS
0.87100 USD
-0.00360
(-0.41%)
C
CVM
3.77000 USD
0.19000
(5.31%)
F
FATE
1.13500 USD
-0.02500
(-2.16%)
G
GOSS
0.47200 USD
0.01190
(2.59%)
I
INO
1.70000 USD
0.05000
(3.03%)
J
JAZZ
181.290 USD
-0.760
(-0.42%)
K
KALA
0.24980 USD
-0.01640
(-6.16%)
K
KURA
8.58500 USD
-0.14500
(-1.66%)
M
MBRX
2.12000 USD
0.08000
(3.92%)
M
MGNX
3.08500 USD
-0.01500
(-0.48%)
MRNA
MRNA
53.920 USD
0.600
(1.13%)
N
NKTR
75.050 USD
2.950
(4.09%)
R
RARE
21.590 USD
-0.220
(-1.01%)
S
SRPT
16.850 USD
0.195
(1.17%)
S
STOK
32.800 USD
-1.150
(-3.39%)
V
VCEL
32.500 USD
0.200
(0.62%)
W
WVE
12.460 USD
0.070
(0.57%)
More

Title: Aclaris Therapeutics

Sector: Healthcare
Industry: Biotechnology
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the following key product candidates: Bosakitug (ATI-045), an investigational, novel, humanized anti-TSLP monoclonal antibody being developed for patients with severe asthma, COPD, and chronic rhinosinusitis with nasal polyps; ATI-2138, being developed for the potential treatment of T cell-mediated autoimmune diseases; and ATI-052 and ATI-9494. Additionally, it has an investigational product candidate, Lepzacitinib (ATI-1777), which is being focused upon as a potential treatment for atopic dermatitis and potentially other dermatologic conditions.
Smarter Decisions,Together
FacebookTwitterYoutubeLinkedIn
App Store
iOS
Google Play
Android
Social Network
The NetworkSignals NetworkIdeas NetworkBest TradersUser Reviews for Brokers
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHouse rulesHelp Centeradvertising with ArincenOur servicesReferral programDownload Mobile App
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.